Chlamydia trachomatis Incidence and Re-Infection among Young Women – Behavioural and Microbiological Characteristics

Background This study aimed to estimate rates of chlamydia incidence and re-infection and to investigate the dynamics of chlamydia organism load in prevalent, incident and re-infections among young Australian women. Methods 1,116 women aged 16 to 25 years were recruited from primary care clinics in Australia. Vaginal swabs were collected at 3 to 6 month intervals for chlamydia testing. Chlamydia organism load was measured by quantitative PCR. Results There were 47 incident cases of chlamydia diagnosed and 1,056.34 person years of follow up with a rate of 4.4 per 100 person years (95% CI: 3.3, 5.9). Incident infection was associated with being aged 16 to 20 years [RR = 3.7 (95%CI: 1.9, 7.1)], being employed [RR = 2.4 (95%CI: 1.1, 4.9)] and having two or more new sex partners [RR = 5.5 (95%CI: 2.6, 11.7)]. Recent antibiotic use was associated with a reduced incidence [RR:0.1 (95%CI: 0.0, 0.5)]. There were 14 re-infections with a rate of 22.3 per 100 person years (95%CI: 13.2, 37.6). The median time to re-infection was 4.6 months. Organism load was higher for prevalent than incident infections (p<0.01) and for prevalent than re-infections (p<0.01). Conclusions Chlamydia is common among young women and a high proportion of women are re-infected within a short period of time, highlighting the need for effective partner treatment and repeat testing. The difference in organism load between prevalent and incident infections suggests prevalent infection may be more important for ongoing transmission of chlamydia.

[1]  P. Horner Azithromycin antimicrobial resistance and genital Chlamydia trachomatis infection: duration of therapy may be the key to improving efficacy , 2012, Sexually Transmitted Infections.

[2]  J. Kaldor,et al.  Interventions to Increase Rescreening for Repeat Chlamydial Infection , 2012, Sexually transmitted diseases.

[3]  H. Handsfield Questioning azithromycin for chlamydial infection. , 2011, Sexually transmitted diseases.

[4]  N. Verlander,et al.  Genital chlamydial infection: association between clinical features, organism genotype and load. , 2011, Journal of medical microbiology.

[5]  S. Garland,et al.  Maximising retention in a longitudinal study of genital Chlamydia trachomatis among young women in Australia , 2011, BMC public health.

[6]  S. Garland,et al.  'The difference in determinants of Chlamydia trachomatis and Mycoplasma genitalium in a sample of young Australian women.' , 2011, BMC infectious diseases.

[7]  Mirjam Kretzschmar,et al.  The role of reinfection and partner notification in the efficacy of Chlamydia screening programs. , 2011, The Journal of infectious diseases.

[8]  Robert E. Johnson,et al.  Protective immunity to Chlamydia trachomatis genital infection: evidence from human studies. , 2010, The Journal of infectious diseases.

[9]  N. Low,et al.  Risk of sequelae after Chlamydia trachomatis genital infection in women. , 2010, The Journal of infectious diseases.

[10]  R. Verheij,et al.  Trends in sexually transmitted infections in the Netherlands, combining surveillance data from general practices and sexually transmitted infection centers , 2010, BMC family practice.

[11]  S. Garland,et al.  Development and Evaluation of an ompA Quantitative Real-Time PCR Assay for Chlamydia trachomatis Serovar Determination , 2010, Journal of Clinical Microbiology.

[12]  M. Unemo,et al.  Characterisation of Chlamydia trachomatis by ompA sequencing and multilocus sequence typing in a Swedish county before and after identification of the new variant , 2009, Sexually Transmitted Infections.

[13]  Richard T. Gray,et al.  Modeling the impact of potential vaccines on epidemics of sexually transmitted Chlamydia trachomatis infection. , 2009, The Journal of infectious diseases.

[14]  L. Gurrin,et al.  Screening pregnant women for chlamydia: what are the predictors of infection? , 2008, Sexually Transmitted Infections.

[15]  J. Peipert,et al.  Chlamydia Antibodies, Chlamydia Heat Shock Protein, and Adverse Sequelae After Pelvic Inflammatory Disease: The PID Evaluation and Clinical Health (PEACH) Study , 2008, Sexually transmitted diseases.

[16]  S. M. Rogers,et al.  Concordance of chlamydia trachomatis infections within sexual partnerships , 2007, Sexually Transmitted Infections.

[17]  S. Lydersen,et al.  Births and Ectopic Pregnancies in a Large Cohort of Women Tested for Chlamydia trachomatis , 2007, Sexually transmitted diseases.

[18]  Helen H. Lee,et al.  Chlamydia trachomatis Load at Matched Anatomic Sites: Implications for Screening Strategies , 2007, Journal of Clinical Microbiology.

[19]  J. Hocking,et al.  Antibiotic consumption and chlamydia prevalence in international studies. , 2006, Sexual health.

[20]  S. Garland,et al.  A chlamydia prevalence survey of young women living in Melbourne, Victoria. , 2006, Sexual health.

[21]  A. Davies,et al.  Incidence and reinfection rates of genital chlamydial infection among women aged 16–24 years attending general practice, family planning and genitourinary medicine clinics in England: a prospective cohort study by the Chlamydia Recall Study Advisory Group , 2006, Sexually Transmitted Infections.

[22]  P. Horner,et al.  The case for further treatment studies of uncomplicated genital Chlamydia trachomatis infection , 2006, Sexually Transmitted Infections.

[23]  C. Hoebe,et al.  Reinfections, Persistent Infections, and New Infections After General Population Screening for Chlamydia trachomatis Infection in The Netherlands , 2005, Sexually transmitted diseases.

[24]  R. Brunham,et al.  Immunoepidemiologic profile of Chlamydia trachomatis infection: importance of heat-shock protein 60 and interferon- gamma. , 2005, The Journal of infectious diseases.

[25]  R. Peeling,et al.  Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis: a meeting report. , 2005, The Journal of infectious diseases.

[26]  S. Franceschi,et al.  The natural course of Chlamydia trachomatis infection in asymptomatic Colombian women: a 5-year follow-up study. , 2005, The Journal of infectious diseases.

[27]  R. Kaslow,et al.  Epidemiological and genetic correlates of incident Chlamydia trachomatis infection in North American adolescents. , 2004, The Journal of infectious diseases.

[28]  S. Garland,et al.  Characterization of Chlamydia trachomatis omp1 Genotypes Detected in Eye Swab Samples from Remote Australian Communities , 2004, Journal of Clinical Microbiology.

[29]  J. Fortenberry,et al.  Patient-Delivered Partner Treatment With Azithromycin to Prevent Repeated Chlamydia trachomatis Infection Among Women: A Randomized, Controlled Trial , 2003, Sexually transmitted diseases.

[30]  W. Whittington,et al.  Quantitative culture of Chlamydia trachomatis: relationship of inclusion-forming units produced in culture to clinical manifestations and acute inflammation in urogenital disease. , 2001, The Journal of infectious diseases.

[31]  J. Schillinger,et al.  Repeat Chlamydia trachomatis infection in women: analysis through a surveillance case registry in Washington State, 1993-1998. , 2000, American journal of epidemiology.

[32]  W. Stamm,et al.  Quantitative Chlamydia trachomatis cultures: correlation of chlamydial inclusion-forming units with serovar, age, sex, and race. , 2000, The Journal of infectious diseases.

[33]  H. Caldwell,et al.  Subclinical Chlamydial Infection of the Female Mouse Genital Tract Generates a Potent Protective Immune Response: Implications for Development of Live Attenuated Chlamydial Vaccine Strains , 2000, Infection and Immunity.

[34]  J B Carlin,et al.  Analysis of binary outcomes in longitudinal studies using weighted estimating equations and discrete-time survival methods: prevalence and incidence of smoking in an adolescent cohort. , 1999, Statistics in medicine.

[35]  G. Cloud,et al.  Risk for gonococcal and chlamydial cervicitis in adolescent females: incidence and recurrence in a prospective cohort study. , 1996, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[36]  Gl Ridgway,et al.  Principles and Practice of Infectious Diseases , 1990 .

[37]  T. Schwarz,et al.  [Genital chlamydial infections]. , 1986, Wiener klinische Wochenschrift.

[38]  J. Paavonen,et al.  Comparison of endometrial biopsy and peritoneal fluid cytologic testing with laparoscopy in the diagnosis of acute pelvic inflammatory disease. , 1985, American journal of obstetrics and gynecology.

[39]  J. Fortenberry,et al.  Repeated Chlamydia trachomatis genital infections in adolescent women. , 2010, The Journal of infectious diseases.

[40]  D. Dean,et al.  Correlating Chlamydia trachomatis infectious load with urogenital ecological success and disease pathogenesis. , 2006, Microbes and infection.

[41]  W. M. Mac Kenzie,et al.  Recurrent chlamydial infections increase the risks of hospitalization for ectopic pregnancy and pelvic inflammatory disease. , 1997, American journal of obstetrics and gynecology.

[42]  G. Byrne,et al.  Immunity to Chlamydia: comparison of human infections and murine models. , 1996, Research in immunology.

[43]  John E. Bennett,et al.  Principles and practice of infectious diseases. Vols 1 and 2. , 1979 .